68180-758Level 3
Amlodipine Besylate and Benazepril Hydrochloride (Amlodipine Besylate and Benazepril Hydrochloride)
**Product type:** Human Prescription Drug
**Active ingredient:** AMLODIPINE BESYLATE; BENAZEPRIL HYDROCHLORIDE
**Strength:** 10; 20 mg/1; mg/1
**Dosage form:** Capsule
**Route:** Oral
**Labeler:** Lupin Pharmaceuticals, Inc.
**Marketing category:** ANDA (ANDA078466)
**Pharmacologic class:** Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Decreased Blood Pressure [PE], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]
GET
/api/v1/systems/ndc_fda/nodes/68180-758Hierarchy Explorer
Loading...
Cross-system equivalences0
No cross-system equivalences mapped for this node.